Prognostic Analysis of Very Early Onset Pancreatic Cancer: a Population-based Analysis

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2020 Feb 26

PMID 32095324

Citations 6

Authors

Dongjun Dai

Yanmei Wang

Xinyang Hu

Hongchuan Jin

Xian Wang

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to use competing risk model to assess whether very early onset pancreatic cancer (VEOPC ) (<45 years) had a worse prognosis than older pancreatic cancer (PC) patients, and to build a competing risk nomogram for predicting the risk of death of VEOPC.

Methods: We selected pancreatic adenocarcinoma (PDAC) patients as our cohort from the Surveillance, Epidemiology, and End Results (SEER) database. The impact of cancer specific death was estimated by competing risk analysis. Multivariate Fine-Gray regression for proportional hazards modeling of the subdistribution hazard (SH) model based nomogram was constructed, which was internally validated by discrimination and calibration with 1,000 bootstraps.

Results: Our cohort included 1,386 VEOPC patients and 53,940 older patients. We observed that in unresectablePDAC patients, VEOPC had better cancer specific survival (CSS) than each older group (45-59 years, 60-69 years, 70-79 years and >79 years). There was no significant prognostic difference between VEOPC and each older group in resectablePDAC. Our competing nomogram showed well discrimination and calibration by internal validation.

Conclusion: For unresectable PDAC patients, VEOPC had better CSS than older patients. Our competing risk nomogram might be an easy-to-use tool for the specific death prediction of VEOPC patients with PDAC.

Citing Articles

Early onset pancreatic cancer: A review.

Luo D, Li Y, Yu X, Ji L, Gong X Transl Oncol. 2024; 52():102239.

PMID: 39672003 PMC: 11699111. DOI: 10.1016/j.tranon.2024.102239.

The Association between Early-Onset Pancreatic Ductal Adenocarcinoma and Patients Survival: A Systematic Review and Meta-Analysis.

Renaldi K, William A F1000Res. 2024; 13:976.

PMID: 39355802 PMC: 11443187. DOI: 10.12688/f1000research.153743.1.

Development and external validation of a prognostic nomogram to predict survival in patients aged ≥60 years with pancreatic ductal adenocarcinoma.

Zheng B, Ding G, Lu G, Li L Transl Cancer Res. 2024; 13(6):2751-2766.

PMID: 38988930 PMC: 11231776. DOI: 10.21037/tcr-24-5.

Lymph node ratio is a superior predictor in surgically treated early-onset pancreatic cancer.

Zheng Y, Lu Z, Shi X, Tan T, Xing C, Xu J Front Oncol. 2022; 12:975846.

PMID: 36119520 PMC: 9479329. DOI: 10.3389/fonc.2022.975846.

Characteristics, Prognosis, and Competing Risk Nomograms of Cutaneous Malignant Melanoma: Evidence for Pigmentary Disorders.

Li Z, Li X, Yi X, Li T, Huang X, Ren X Front Oncol. 2022; 12:838840.

PMID: 35719966 PMC: 9198425. DOI: 10.3389/fonc.2022.838840.

References

Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Uesaka K . Impact of Patient Age on the Postoperative Survival in Pancreatic Head Cancer. Ann Surg Oncol. 2017; 24(11):3220-3228. DOI: 10.1245/s10434-017-5994-0. View

Balachandran V, Gonen M, Smith J, DeMatteo R . Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015; 16(4):e173-80. PMC: 4465353. DOI: 10.1016/S1470-2045(14)71116-7. View

Fakhry C, Zhang Q, Nguyen-Tan P, Rosenthal D, Weber R, Lambert L . Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017; 35(36):4057-4065. PMC: 5736236. DOI: 10.1200/JCO.2016.72.0748. View

van Eeghen E, Bakker S, van Bochove A, Loffeld R . Impact of age and comorbidity on survival in colorectal cancer. J Gastrointest Oncol. 2015; 6(6):605-12. PMC: 4671847. DOI: 10.3978/j.issn.2078-6891.2015.070. View

Saad A, Turk T, Al-Husseini M, Abdel-Rahman O . Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018; 18(1):688. PMC: 6020186. DOI: 10.1186/s12885-018-4610-4. View

Chen H, Zhou M, Tian W, Meng K, He H . Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database. PLoS One. 2016; 11(10):e0165409. PMC: 5087840. DOI: 10.1371/journal.pone.0165409. View

Gallo L, Troxel W, Matthews K, Kuller L . Marital status and quality in middle-aged women: Associations with levels and trajectories of cardiovascular risk factors. Health Psychol. 2003; 22(5):453-63. DOI: 10.1037/0278-6133.22.5.453. View

Lin J, Zhang X, Kou J, Fa H, Zhang X, Dai Y . Analysis of prognostic factors for pancreatic head cancer according to para-aortic lymph node. Cancer Med. 2016; 5(10):2701-2707. PMC: 5083722. DOI: 10.1002/cam4.853. View

Barbas A, Turley R, Ceppa E, Reddy S, Blazer 3rd D, Clary B . Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc. 2012; 60(2):344-50. DOI: 10.1111/j.1532-5415.2011.03785.x. View

10.

Lack E, Cassady J, Levey R, VAWTER G . Tumors of the exocrine pancreas in children and adolescents. A clinical and pathologic study of eight cases. Am J Surg Pathol. 1983; 7(4):319-27. DOI: 10.1097/00000478-198306000-00003. View

11.

Zhang W, Sun B . Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database. Oncotarget. 2015; 6(2):633-41. PMC: 4359244. DOI: 10.18632/oncotarget.2719. View

12.

Kim H . Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res. 2007; 13(2 Pt 1):559-65. DOI: 10.1158/1078-0432.CCR-06-1210. View

13.

Miyazaki Y, Kokudo T, Amikura K, Kageyama Y, Takahashi A, Ohkohchi N . Age does not affect complications and overall survival rate after pancreaticoduodenectomy: Single-center experience and systematic review of literature. Biosci Trends. 2016; 10(4):300-6. DOI: 10.5582/bst.2016.01093. View

14.

Satagopan J, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach A . A note on competing risks in survival data analysis. Br J Cancer. 2004; 91(7):1229-35. PMC: 2410013. DOI: 10.1038/sj.bjc.6602102. View

15.

Rose P, Java J, Whitney C, Stehman F, Lanciano R, Thomas G . Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group.... J Clin Oncol. 2015; 33(19):2136-42. PMC: 4477785. DOI: 10.1200/JCO.2014.57.7122. View

16.

van der Geest L, Besselink M, van Gestel Y, Busch O, de Hingh I, de Jong K . Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands. Acta Oncol. 2015; 55(3):278-85. DOI: 10.3109/0284186X.2015.1105381. View

17.

Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P . Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol. 2017; 29(2):377-385. DOI: 10.1093/annonc/mdx742. View

18.

Herberman R, Ortaldo J . Natural killer cells: their roles in defenses against disease. Science. 1981; 214(4516):24-30. DOI: 10.1126/science.7025208. View

19.

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

20.

Shorter N, Glick R, Klimstra D, Brennan M, LaQuaglia M . Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg. 2002; 37(6):887-92. DOI: 10.1053/jpsu.2002.32897. View